Our first edition of 2022 focuses on Healthcare and Life Sciences. It is a sector that will once again have the spotlight on it this year as we continue to tackle COVID-19 and its subsequent variants. While the pandemic continues to challenge the sector, governments across the region forge ahead with their plans to expand and upgrade healthcare systems and develop robust world-class healthcare infrastructure.
For the region, healthcare is a vital pillar in diversifying its economies, both locally and as medical tourism hubs. To underpin this, healthcare authorities across the region continue to implement frameworks and regulations that provide structure and accountability.
In this edition, you have unique access to great insights and expert commentary on a number of pertinent healthcare regulatory developments. You will find a topical mix of articles; for example, our lawyers discuss vaccines and returning to work during the pandemic. They take you through several other areas, including stem cell research in Bahrain, clinical research laws in Egypt, and Saudi medical device and pharmaceutical laws.Take a read of the edition
Partner and Head of Advisory Ibtissem Lassoued (Regional Financial Crime practice) was featured on a guest segment for Bloomberg as she was invited this week to address the implications of the recently published Transparency International Corruption Perceptions Index 2019.
Anti-corruption is a strategically important issue, not only for the Middle East but for all markets attempting to attract foreign investment. This year’s ranking showed positive moves for the UAE, Saudi Arabia and Bahrain which they will hope to build on in future.